Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Danoprevir
2. Itmn 191
3. Itmn-191
4. Itmn191
5. R 7227
6. R-7227
7. R7227 Cpd
8. Rg 7227
9. Rg-7227
10. Rg7227
1. Danoprevir
2. 850876-88-9
3. Schembl2833159
4. Zinc150357979
5. Cs-0337
6. Ac-32903
7. Hy-10238
8. 2h-isoindole-2-carboxylic Acid, 4-fluoro-1,3-dihydro-, (2r,6s,13as,14ar,16as)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl Ester
| Molecular Weight | 731.8 g/mol |
|---|---|
| Molecular Formula | C35H46FN5O9S |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 8 |
| Exact Mass | 731.30002740 g/mol |
| Monoisotopic Mass | 731.30002740 g/mol |
| Topological Polar Surface Area | 189 Ų |
| Heavy Atom Count | 51 |
| Formal Charge | 0 |
| Complexity | 1530 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Danoprevir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Danoprevir, including repackagers and relabelers. The FDA regulates Danoprevir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Danoprevir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Danoprevir supplier is an individual or a company that provides Danoprevir active pharmaceutical ingredient (API) or Danoprevir finished formulations upon request. The Danoprevir suppliers may include Danoprevir API manufacturers, exporters, distributors and traders.
Danoprevir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Danoprevir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Danoprevir GMP manufacturer or Danoprevir GMP API supplier for your needs.
A Danoprevir CoA (Certificate of Analysis) is a formal document that attests to Danoprevir's compliance with Danoprevir specifications and serves as a tool for batch-level quality control.
Danoprevir CoA mostly includes findings from lab analyses of a specific batch. For each Danoprevir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Danoprevir may be tested according to a variety of international standards, such as European Pharmacopoeia (Danoprevir EP), Danoprevir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Danoprevir USP).
LOOKING FOR A SUPPLIER?
